Glenmark to spin off its innovation business into a new company in the U.S.
PARAMUS, N.J. — Glenmark Pharmaceuticals announced that its board of directors has given an in-principle approval to spin off the innovation business into a new company in the U.S. Setting up of the new company will provide an enhanced focus to the innovation business and help accelerate the pipeline towards commercialization. The new innovation company will
